Delivery Order SPE2DB22D1202-SPE2DB25FUVE7
Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $27,920 on August 25, 2025, by the Medical Supply Chain division of the Defense Logistics Agency. The contract, which represents a child order under a larger Indefinite Delivery Contract framework, calls for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pre-filled pens. This is a firm fixed price, competitively awarded delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $8,653.84 for Zepbound (tirzepatide) 15 mg/0.5 mL pens. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $98,947 by the Defense Logistics Agency for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injections, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order execution under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,481.93 by the Defense Logistics Agency on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract is for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen auto-injectors in 0.5 mL dosages. The award carries no set-aside designation and represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,575.52 on August 27, 2025, for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pens in 0.5 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $35,643.13 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens with a ceiling value of $21,468.56. This is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $11,057.47 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 10 mg/0.5 ml pen injections on August 8, 2025. This firm fixed-price delivery order, with a completion date of August 11, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $24,451.56 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens. This competitive, non-set-aside contract utilizes firm fixed pricing and has an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order falls under the company's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,055.15 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens on September 12, 2025, with completion anticipated by September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...